Skip to main content

Arcxis Lands $1M Homeland Security Award for DNA-Based Anthrax, Plague Dx

NEW YORK (GenomeWeb News) — Arcxis Biotechnologies has received a $1 million Phase II award from the US Department of Homeland Security to continue developing its BioPhalanx instrument, a portable, rapid-detection bio-threat analyzer, the company said Tuesday. 
 
The Pleasanton, Calif.-based company said the funding comes after it demonstrated a genomic probe assay for viruses causing anthrax and plague that does not report false positive results.
  
Arcxis said the assays will combine its micro-preparation cards for rapid sample preparation, micro channel-based microarrays for detecting nucleic acids, and its so-called "tentacle probes" for designing specific assays targeted at bio-threats.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.